Amygdalin inhibits HSC-T6 cell proliferation and fibrosis through the regulation of TGF-β/CTGF
暂无分享,去创建一个
Xinhua Wang | Liang Li | D. Sun | Fengling Zheng | Jianbang Tang | Huanhuan Luo | Feng-xue Zhang | Fang Zhao
[1] S. Friedman,et al. Hepatic stellate cells and liver fibrosis. , 2013, Comprehensive Physiology.
[2] Hong Wang,et al. Expression of ectonucleotide pyrophosphatase‐1 in end‐plate chondrocytes with transforming growth factor beta 1 siRNA interference by cyclic mechanical tension , 2013, Chinese medical journal.
[3] C. Meyer,et al. Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation* , 2013, Journal of Biological Chemistry.
[4] Jian-ming Tan,et al. Amygdalin inhibits renal fibrosis in chronic kidney disease. , 2013, Molecular medicine reports.
[5] Haiyan Song,et al. Danshensu inhibits acetaldehyde-induced proliferation and activation of hepatic stellate cell-T6. , 2012, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.
[6] K. Lipson,et al. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis , 2012, Fibrogenesis & tissue repair.
[7] D. Brigstock,et al. Regulation of hepatic stellate cells by connective tissue growth factor. , 2012, Frontiers in bioscience.
[8] A. Esteghamati,et al. Amygdalin inhibits angiogenesis in the cultured endothelial cells of diabetic rats. , 2012, Indian journal of pathology & microbiology.
[9] Katsunori Yoshida,et al. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries , 2012, Front. Physio..
[10] S. Friedman,et al. Mechanisms of hepatic fibrogenesis. , 2011, Best practice & research. Clinical gastroenterology.
[11] S. Friedman,et al. Pathogenesis of liver fibrosis. , 2011, Annual review of pathology.
[12] A. Gressner,et al. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases , 2008, Liver international (Print).
[13] Young Yang,et al. Antinociceptive effect of amygdalin isolated from Prunus armeniaca on formalin-induced pain in rats. , 2008, Biological & pharmaceutical bulletin.
[14] Natalie J Torok. Recent advances in the pathogenesis and diagnosis of liver fibrosis. , 2008 .
[15] M. Domenico,et al. New therapeutic approaches to liver fibrosis: a practicable route? , 2008 .
[16] Lai Wei,et al. Effect of interferon-gamma on hepatic stellate cells stimulated by acetaldehyde. , 2008, Hepato-gastroenterology.
[17] G. Tseng,et al. Mechanisms of hepatocyte growth factor–mediated and epidermal growth factor–mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium , 2008, Hepatology.
[18] E. Mezey,et al. Acetaldehyde increases endogenous adiponectin and fibrogenesis in hepatic stellate cells but exogenous adiponectin inhibits fibrogenesis. , 2007, Alcoholism, clinical and experimental research.
[19] Y. Inagaki,et al. Emerging insights into Transforming growth factor β Smad signal in hepatic fibrogenesis , 2007, Gut.
[20] K. Kim,et al. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. , 2006, Biological & pharmaceutical bulletin.
[21] Junho Chung,et al. Detection of abnormally high amygdalin content in food by an enzyme immunoassay. , 2006, Molecules and cells.
[22] Fang Liu,et al. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. , 2005, Journal of the American Society of Nephrology : JASN.
[23] R. Wells. The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. , 2005, Journal of clinical gastroenterology.
[24] Katsunori Yoshida,et al. Transforming growth factor-β and platelet-derived growth factor signal via c-jun N-terminal kinase- dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury , 2005 .
[25] Hideyuki Ito,et al. Anti-tumor promoting effect of glycosides from Prunus persica seeds. , 2003, Biological & pharmaceutical bulletin.
[26] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[27] H. Friess,et al. Connective tissue growth factor in human liver cirrhosis. , 2000, Liver.
[28] M. Arthur,et al. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. , 2000, Journal of hepatology.
[29] K. Matsuzaki,et al. Modulation of transforming growth factor β function in hepatocytes and hepatic stellate cells in rat liver injury , 2000, Gut.
[30] S. Friedman. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.
[31] J. Iredale,et al. Pathogenesis of liver fibrosis. , 1997, Clinical science.
[32] N. Török. Recent advances in the pathogenesis and diagnosis of liver fibrosis , 2008, Journal of Gastroenterology.
[33] G. Ambrosino,et al. New therapeutic approaches to liver fibrosis: a practicable route? , 2008, Current medicinal chemistry.
[34] P. Bioulac-Sage,et al. [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[35] A. Gressner. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. , 1995, Journal of hepatology.
[36] Gressner Am. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. , 1995 .